In vitro and in vivo experiments were conducted to evaluate the effects of SLC10A3 knockdown on GBM malignant phenotypes and macrophage recruitment.<h4>Results</h4>SLC10A3 was significantly overexpressed in GBM and associated with poor prognosis. This evidence concerns the gene SLC10A3 and glioblastoma.